Cite
Klepetko W, Estenne M, Glanville A, et al. A multicenter study to assess outcome following a switch in the primary immunosuppressant from cyclosporin (CYA) to tacrolimus (TAC) in lung recipients. J Heart Lung Transplant. 2001;20(2):208doi: 10.1016/s1053-2498(00)00448-4.
Klepetko, W., Estenne, M., Glanville, A., Verleden, G., Aubert, J. D., Sarahrudi, K., Gerbase, M., Hirt, S., Reichenspurner, H., & Ploner, M. (2001). A multicenter study to assess outcome following a switch in the primary immunosuppressant from cyclosporin (CYA) to tacrolimus (TAC) in lung recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 20(2), 208. https://doi.org/10.1016/s1053-2498(00)00448-4
Klepetko, W, et al. "A multicenter study to assess outcome following a switch in the primary immunosuppressant from cyclosporin (CYA) to tacrolimus (TAC) in lung recipients." The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. 20,2 (2001): 208. doi: https://doi.org/10.1016/s1053-2498(00)00448-4
Klepetko W, Estenne M, Glanville A, Verleden G, Aubert JD, Sarahrudi K, Gerbase M, Hirt S, Reichenspurner H, Ploner M. A multicenter study to assess outcome following a switch in the primary immunosuppressant from cyclosporin (CYA) to tacrolimus (TAC) in lung recipients. J Heart Lung Transplant. 2001 Feb;20(2):208. doi: 10.1016/s1053-2498(00)00448-4. PMID: 11250377.
Copy
Download .nbib